Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   SHIRAZ E MEDICAL JOURNAL   JULY 2011 , Volume 12 , Number 3; Page(s) 162 To 164.
 
Paper: 

IMATINIB INDUCED FACIAL SKIN HYPERPIGMENTATION IN A CASE OF CHRONIC MYELOGENOUS LEUKEMIA

 
 
Author(s):  VALIZADEH N.*
 
* DEPARTMENT OF MEDICINE, URMIA UNIVERSITY OF MEDICAL SCIENCES, URMIA, IRAN
 
Abstract: 
Background: Imatinib is a tyrosine kinase inhibitor (TKI) which targets BCR-ABL protein in patients with chronic myelogenous leukemia (CML) and c-kit in patients with gastrointestinal stromal tumors (GISTs). Skin hypopigmentation is reported during Imatinib therapy. We present a case of CML who developed skin hyperpigmentation in the face during treatment with Imatinib which found chloasma-like appearance.
 
Keyword(s): IMATINIB, SKIN, HYPERPIGMENTATION, CHLOASMA
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 80
 
Latest on Blog
Enter SID Blog